TY - JOUR
T1 - Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider
T2 - Part 2: at the emergency department
AU - Milicic, Davor
AU - Ben Avraham, Binyamin
AU - Chioncel, Ovidiu
AU - Barac, Yaron D.
AU - Goncalvesova, Eva
AU - Grupper, Avishai
AU - Altenberger, Johann
AU - Frigeiro, Maria
AU - Ristic, Arsen
AU - De Jonge, Nicolaas
AU - Tsui, Steven
AU - Lavee, Jacob
AU - Rosano, Giuseppe
AU - Crespo-Leiro, Marisa Generosa
AU - Coats, Andrew J.S.
AU - Seferovic, Petar
AU - Ruschitzka, Frank
AU - Metra, Marco
AU - Anker, Stefan
AU - Filippatos, Gerasimos
AU - Adamopoulos, Stamatis
AU - Abuhazira, Miriam
AU - Elliston, Jeremy
AU - Gotsman, Israel
AU - Hamdan, Righab
AU - Hammer, Yoav
AU - Hasin, Tal
AU - Hill, Lorrena
AU - Itzhaki Ben Zadok, Osnat
AU - Mullens, Wilfried
AU - Nalbantgil, Sanemn
AU - Piepoli, Massimo Francesco
AU - Ponikowski, Piotr
AU - Potena, Luciano
AU - Ruhparwar, Arjang
AU - Shaul, Aviv
AU - Tops, Laurens F.
AU - Winnik, Stephan
AU - Jaarsma, Tiny
AU - Gustafsson, Finn
AU - Ben Gal, Tuvia
N1 - Publisher Copyright:
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
PY - 2021/12
Y1 - 2021/12
N2 - The improvement in left ventricular assist device (LVAD) technology and scarcity of donor hearts have increased dramatically the population of the LVAD-supported patients and the probability of those patients to present to the emergency department with expected and non-expected device-related and patient–device interaction complications. The ageing of the LVAD-supported patients, mainly those supported with the ‘destination therapy’ indication, increases the risk for those patients to suffer from other co-morbidities common in the older population. In this second part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, definitions and structured approach to the LVAD-supported patient presenting to the emergency department with bleeding, neurological event, pump thrombosis, chest pain, syncope, and other events are presented. The very challenging issue of declaring death in an LVAD-supported patient, as the circulation is artificially preserved by the device despite no other signs of life, is also discussed in detail.
AB - The improvement in left ventricular assist device (LVAD) technology and scarcity of donor hearts have increased dramatically the population of the LVAD-supported patients and the probability of those patients to present to the emergency department with expected and non-expected device-related and patient–device interaction complications. The ageing of the LVAD-supported patients, mainly those supported with the ‘destination therapy’ indication, increases the risk for those patients to suffer from other co-morbidities common in the older population. In this second part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, definitions and structured approach to the LVAD-supported patient presenting to the emergency department with bleeding, neurological event, pump thrombosis, chest pain, syncope, and other events are presented. The very challenging issue of declaring death in an LVAD-supported patient, as the circulation is artificially preserved by the device despite no other signs of life, is also discussed in detail.
UR - http://www.scopus.com/inward/record.url?scp=85115100355&partnerID=8YFLogxK
U2 - 10.1002/ehf2.13587
DO - 10.1002/ehf2.13587
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34523254
AN - SCOPUS:85115100355
SN - 2055-5822
VL - 8
SP - 4409
EP - 4424
JO - ESC heart failure
JF - ESC heart failure
IS - 6
ER -